Natera (NASDAQ:NTRA) Insider John Fesko Sells 931 Shares of Stock

Key Points

• Insider John Fesko sold 931 Natera shares at an average price of $254.07, generating $236,539.17. The Rule 10b5-1 sale was made to cover tax withholding tied to vested equity awards, reducing his holdings by 0.5% to 184,069 shares.
• Natera shares traded around $253.82, with a 52-week range of $131.81 to $288.04 and a market capitalization of approximately $36.35 billion.
• Analysts maintain a “Moderate Buy” consensus on Natera, with an average price target of $267.83; institutional investors own approximately 99.9% of the stock.

Natera, Inc. (NASDAQ:NTRA - Get Free Report) insider John Fesko sold 931 shares of the business's stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $254.07, for a total transaction of $236,539.17. Following the sale, the insider directly owned 184,069 shares in the company, valued at approximately $46,766,410.83. The trade was a 0.50% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

John Fesko also recently made the following trade(s):

• On Monday, July 27th, John Fesko sold 782 shares of Natera stock. The stock was sold at an average price of $260.49, for a total transaction of $203,703.18.
• On Tuesday, May 26th, John Fesko sold 1,438 shares of Natera stock. The shares were sold at an average price of $202.84, for a total value of $291,683.92.
• On Friday, May 1st, John Fesko sold 291 shares of Natera stock. The shares were sold at an average price of $206.16, for a total value of $59,992.56.

Natera Price Performance

NTRA stock traded up $1.60 during midday trading on Wednesday, reaching $253.82. 925,147 shares of the stock were exchanged, compared to its average volume of 1,091,572. The stock has a market capitalization of $36.35 billion, a PE ratio of -155.72 and a beta of 1.51. Natera, Inc. has a 52 week low of $131.81 and a 52 week high of $288.04. The company has a fifty day moving average price of $244.16 and a 200 day moving average price of $221.65.

Wall Street Analysts Forecast Growth

NTRA has been the topic of several research reports. Wells Fargo & Company boosted their price target on Natera from $215.00 to $220.00 and gave the stock an "equal weight" rating in a report on Friday, May 8th. Wolfe Research initiated coverage on shares of Natera in a research report on Tuesday, June 2nd. They set an "outperform" rating and a $260.00 target price on the stock. Morgan Stanley lifted their target price on shares of Natera from $250.00 to $310.00 and gave the stock an "overweight" rating in a research report on Thursday, July 9th. Piper Sandler reissued an "overweight" rating and set a $249.00 target price on shares of Natera in a report on Tuesday, May 12th. Finally, The Goldman Sachs Group started coverage on shares of Natera in a research report on Friday, June 5th. They issued a "neutral" rating and a $245.00 price target for the company. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Natera presently has a consensus rating of "Moderate Buy" and a consensus price target of $267.83.

Hedge Funds Weigh In On Natera

Hedge funds have recently made changes to their positions in the stock. Reflection Asset Management acquired a new position in shares of Natera in the fourth quarter worth approximately $29,000. Elevation Wealth Partners LLC acquired a new stake in Natera during the 2nd quarter valued at approximately $30,000. Palladiem LLC acquired a new stake in Natera during the 4th quarter valued at approximately $31,000. Horizon Investments LLC bought a new position in Natera during the 3rd quarter worth approximately $32,000. Finally, International Assets Investment Management LLC raised its holdings in Natera by 132.9% during the 1st quarter. International Assets Investment Management LLC now owns 170 shares of the medical research company's stock worth $35,000 after purchasing an additional 97 shares during the last quarter. 99.90% of the stock is currently owned by institutional investors.

About Natera

Natera is a global diagnostics company that develops and commercializes cell-free DNA and other genetic testing technologies for clinical applications. The company focuses on three principal areas: reproductive health (including non-invasive prenatal testing and carrier screening), oncology (tumor-informed assays for minimal residual disease and recurrence monitoring), and organ transplantation (cell-free DNA tests to detect allograft injury). Natera combines laboratory testing, proprietary bioinformatics, and clinical reporting to deliver personalized genetic information to clinicians and patients.

Key product offerings include Panorama, a non-invasive prenatal test that screens for fetal chromosomal abnormalities and select single-gene conditions; Horizon carrier screening for inherited conditions; Signatera, a personalized, tumor-informed assay used for detecting minimal residual disease and monitoring treatment response in cancer patients; and Prospera, a donor-derived cell-free DNA test used to assess the risk of organ rejection.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.